188 related articles for article (PubMed ID: 2861127)
1. Effect of low-dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese nondiabetic human subjects.
Schusdziarra V; Lawecki J; Ditschuneit HH; Lukas B; Maier V; Pfeiffer EF
Diabetes; 1985 Jun; 34(6):595-601. PubMed ID: 2861127
[TBL] [Abstract][Full Text] [Related]
2. Increased sensitivity to somatostatin in obese Zucker rats.
Bender H; Schusdziarra V; Pfeiffer EF
Clin Physiol Biochem; 1985; 3(1):1-7. PubMed ID: 2859937
[TBL] [Abstract][Full Text] [Related]
3. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
Gutniak M; Grill V; Efendić S
J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
[TBL] [Abstract][Full Text] [Related]
4. Modulatory effect of glucose, amino acids, and secretin on CCK-8-induced somatostatin and pancreatic polypeptide release in dogs.
Schusdziarra V; Lenz N; Schick R; Maier V
Diabetes; 1986 May; 35(5):523-9. PubMed ID: 2869995
[TBL] [Abstract][Full Text] [Related]
5. Infusion of graded concentrations of somatostatin in man: pharmacokinetics and differential inhibitory effects on pituitary and islet hormones.
Skamene A; Patel YC
Clin Endocrinol (Oxf); 1984 May; 20(5):555-64. PubMed ID: 6146413
[TBL] [Abstract][Full Text] [Related]
6. Circulating amino acids and pancreatic endocrine function after ingestion of a protein-rich meal in obese subjects.
Schmid R; Schusdziarra V; Schulte-Frohlinde E; Maier V; Classen M
J Clin Endocrinol Metab; 1989 Jun; 68(6):1106-10. PubMed ID: 2656733
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent inhibitory and non-inhibitory action of somatostatin on insulin release in rats.
Schusdziarra V; Bender H; Torres A; Pfeiffer EF
Regul Pept; 1982 Aug; 4(3):147-53. PubMed ID: 6127757
[TBL] [Abstract][Full Text] [Related]
8. Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 2). Effects on basal release of somatostatin and pancreatic polypeptide.
Ahrén B; Veith RC; Paquette TL; Taborsky GJ
Endocrinology; 1987 Jul; 121(1):332-9. PubMed ID: 2885175
[TBL] [Abstract][Full Text] [Related]
9. Basal and meal-induced somatostatin-like immunoreactivity in healthy subjects and in IDDM and totally pancreatectomized patients. Effects of acute blood glucose normalization.
Gutniak M; Grill V; Wiechel KL; Efendić S
Diabetes; 1987 Jul; 36(7):802-7. PubMed ID: 2884157
[TBL] [Abstract][Full Text] [Related]
10. Effect of naloxone on pancreatic and gastric endocrine function in response to carbohydrate and fat-rich test meals.
Schusdziarra V; Holland A; Maier V; Pfeiffer EF
Peptides; 1984; 5(1):65-71. PubMed ID: 6143305
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a role of splanchnic somatostatin in the homeostasis of ingested nutrients.
Schusdziarra V; Harris V; Arimura A; Unger RH
Endocrinology; 1979 Jun; 104(6):1705-8. PubMed ID: 446390
[TBL] [Abstract][Full Text] [Related]
12. Free somatostatin in the circulation: amounts and molecular sizes of somatostatin-like immunoreactivity in portal, aortic, and vena caval plasma of fasting and meal-stimulated dogs.
Schusdziarra V; Zyznar E; Rouiller D; Harris V; Unger RH
Endocrinology; 1980 Nov; 107(5):1572-6. PubMed ID: 6107241
[TBL] [Abstract][Full Text] [Related]
13. Role of histamine H2-receptors in gastric and pancreatic release of somatostatin-like immunoreactivity during the gastric phase of meal.
Schusdziarra V; Rouiller D; Harris V; Unger RH
Regul Pept; 1981 Feb; 1(5):353-63. PubMed ID: 7255767
[TBL] [Abstract][Full Text] [Related]
14. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL
J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
[TBL] [Abstract][Full Text] [Related]
15. Effect of bombesin upon plasma somatostatin-like immunoreactivity, insulin and glucagon in normal and chemically sympathectomized dogs.
Schusdziarra V; Rouiller D; Harris V; Pfeiffer EF; Unger RH
Regul Pept; 1980 Oct; 1(2):89-96. PubMed ID: 6114514
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin-28 does not regulate islet function in the dog.
Klaff LJ; Dunning BE; Taborsky GJ
Endocrinology; 1988 Dec; 123(6):2668-74. PubMed ID: 2904358
[TBL] [Abstract][Full Text] [Related]
17. Dose-response effect of somatostatin-14 on human basal pancreatic hormones.
Annibale B; Delle Fave G; Barbetti F; de Magistris L; Puoti M; Giordano E; Leonetti F; Tamburrano G
Pancreas; 1987; 2(5):551-6. PubMed ID: 2890157
[TBL] [Abstract][Full Text] [Related]
18. Rate dependent stimulation of insulin and glucagon but not gastrin and somatostatin release during the intestinal phase of a meal.
Schusdziarra V; Dangel G; Henrichs I; Klier M; Pfeiffer EF
Horm Metab Res; 1982 Apr; 14(4):169-71. PubMed ID: 6123480
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.
Taborsky GJ; Ensinck JW
J Clin Invest; 1984 Jan; 73(1):216-23. PubMed ID: 6140271
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic and gastric release of somatostatinlike immunoreactivity during intestinal phase of a meal.
Schusdziarra V; Rouiller D; Pietri A; Harris V; Zyznar E; Conlon JM; Unger RH
Am J Physiol; 1979 Dec; 237(6):E555-60. PubMed ID: 517653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
